Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SEVERFIELD PLC AGM Information 2020

Sep 3, 2020

4741_agm-r_2020-09-03_903ab670-a9d9-40fb-a4be-63c459cbbbc1.html

AGM Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 9853X

Severfield PLC

03 September 2020

SEVERFIELD PLC

Results of Annual General Meeting 2020

At the Company's Annual General Meeting held at 12 noon today, 3 September, all of the resolutions were passed on a show of hands.

Copies of all the resolutions passed have been submitted to the UK Listing Authority via the National Storage Mechanism and will shortly be available for review at Financial Conduct Authority website (https://data.fca.org.uk/#/nsm/nationalstoragemechanism).

A summary of Proxies received in respect of each resolution is set out below (a "vote withheld" is not a vote in law and is not counted in the calculation of the proportion of the votes for and against the resolution):

In Favour Against Total Withheld
Resolution No of   votes % of votes No of votes % of votes No of   votes No of votes
1.   To receive and adopt the annual accounts and the reports of the Directors for the financial year ended 31 March 2020 together with the report of the auditors thereon. 252,370,227 99.99 37,428 0.01 252,407,655 1,544,286
2.   To approve the Directors' remuneration report (other than the part containing the Directors' remuneration policy) for the financial year ended 31 March 2020 as set out in the Annual Report and Accounts 2020. 253,671,011 99.90 242,584 0.10 253,913,595 38,347
3.   To approve the Directors' remuneration policy as set out in the Annual Report and Accounts 2020. 239,038,916 94.71 13,347,225 5.29 252,386,141 1,565,800
4.   To declare a final dividend of 1.8p per ordinary share in respect of the year ended 31 March 2020 payable on 11th September 2020 to shareholders on the register at the close of business on 14th August 2020. 253,953,841 100.00 4,643 0.00 253,958,484 3,458
5.   To reappoint Ian Cochrane as a Director. 246,213,335 96.95 7,738,865 3.05 253,952,200 9,742
6.   To reappoint Alan Dunsmore as a Director. 244,688,208 96.94 7,734,407 3.06 252,422,615 1,539,327
7.   To reappoint Derek Randall as a Director. 246,214,661 96.95 7,733,407 3.05 253,948,068 13,874
8.   To reappoint Adam Semple as a Director. 246,182,778 96.94 7,765,290 3.06 253,948,068 13,874
9.   To reappoint Alun Griffiths as a Director. 253,881,404 99.97 67,338 0.03 253,948,742 13,200
10.  To reappoint Tony Osbaldiston as a Director. 253,927,240 99.99 14,828 0.01 253,942,068 19,874
11.  To reappoint Kevin Whiteman as a Director. 253,877,730 99.97 64,338 0.03 253,942,068 19,874
12.  To appoint Louise Hardy as a Director 253,868,441 99.97 68,167 0.03 253,936,608 25,334
13.  To reappoint KPMG LLP as auditors of the Company to hold office until the conclusion of the next Annual General Meeting of the Company in 2021. 253,714,453 99.95 118,823 0.05 253,833,276 128,666
14.  To authorise the Directors to determine the auditors' remuneration. 253,920,652 99.99 17,457 0.01 253,938,109 23,833
15.  To authorise the Directors to allot securities of the Company. 253,288,366 99.74 666,877 0.26 253,955,243 6,699
16.  To authorise the Directors to dis-apply pre-emption rights in relation to the issue of securities of the Company. 253,628,796 99.88 300,749 0.12 253,929,545 32,397
17.  To authorise the Directors to dis-apply pre-emption rights in connection with an acquisition or specified capital investment. 252,119,401 99.29 1,807,810 0.71 253,927,211 34,730
18.  To authorise the Company to make market purchases of the Company's ordinary shares. 252,196,697 99.31 1,743,286 0.69 253,939,983 21,958
19.  That a general meeting of the Company (other than an annual general meeting) may be called on not less than 14 clear days' notice. 251,970,845 99.23 1,966,700 0.77 253,937,545 24,397

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGGZGGLFFNGGZM